Skip to main content
Download PDF

Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]

BMC Cancer volume 19, Article number: 97 (2019) Cite this article

The Original Article was published on 07 January 2019

Correction to: BMC Cancer

https://doi.org/10.1186/s12885-018-5200-1

Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected.

  • Originally published name:

    • Nicholas Nicholas G. Nickols

  • Correct name:

    • Nicholas G. Nickols

Reference

  1. Calais, et al. Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]. BMC Cancer. 2018;19:18. https://doi.org/10.1186/s12885-018-5200-1.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular & Medical Pharmacology, Ahmanson Translational Theranostics/ Imaging Division, University of California, Los Angeles, USA

    Jeremie Calais, Johannes Czernin & Wolfgang P. Fendler

  2. Department of Nuclear Medicine, University Hospital Essen, Essen, Germany

    Wolfgang P. Fendler

  3. Department of Medicine Statistics Core (DOMStat), UCLA CTSI Biostatistics and Computational Biology, University of California, Los Angeles, USA

    David Elashoff

  4. Department of Radiation Oncology, University of California, Los Angeles, USA

    Nicholas G. Nickols

  5. Department of Radiation Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA

    Nicholas G. Nickols

Authors
  1. Jeremie Calais
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Johannes Czernin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wolfgang P. Fendler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Elashoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nicholas G. Nickols
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jeremie Calais or Johannes Czernin.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Calais, J., Czernin, J., Fendler, W.P. et al. Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]. BMC Cancer 19, 97 (2019). https://doi.org/10.1186/s12885-019-5297-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12885-019-5297-x

BMC Cancer

ISSN: 1471-2407

Contact us